STSS:NSD-Sharps Technology Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 0.3456

Change

0.00 (-0.60)%

Market Cap

USD 4.58M

Volume

0.09M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ISRG Intuitive Surgical Inc

N/A

USD 133.13B
COO The Cooper Companies Inc.

N/A

USD 19.60B
HOLX Hologic Inc

N/A

USD 17.83B
RGEN Repligen Corporation

N/A

USD 9.30B
XRAY Dentsply Sirona Inc

N/A

USD 6.35B
MMSI Merit Medical Systems Inc

N/A

USD 4.28B
AZTA Azenta Inc

N/A

USD 2.91B
ICUI ICU Medical Inc

N/A

USD 2.31B
STAA STAAR Surgical Company

N/A

USD 2.31B
LMAT LeMaitre Vascular Inc

N/A

USD 1.47B

ETFs Containing STSS

PACF:CA Purpose Active Conservati.. 5.80 % 0.00 %

N/A

CAD 0.04B
PINC:CA Purpose Multi-Asset Incom.. 4.81 % 0.99 %

N/A

CAD 0.06B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.90% 31% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.90% 31% F 22% F
Trailing 12 Months  
Capital Gain -72.35% 12% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -72.35% 12% F 10% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -22.74% 16% F 17% F
Dividend Return -22.74% 16% F 16% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 28.83% 75% C 63% D
Risk Adjusted Return -78.89% 14% F 12% F
Market Capitalization 4.58M 3% F 5% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.